EP 1615911 A1 20060118 - 5-HYDROXYINDOLES WITH N-OXIDE GROUPS AND USE THEREOF AS A PHOSPHODIESTERASE 4 INHIBITOR
Title (en)
5-HYDROXYINDOLES WITH N-OXIDE GROUPS AND USE THEREOF AS A PHOSPHODIESTERASE 4 INHIBITOR
Title (de)
5-HYDROXYINDOLE MIT PYRIDIN-N-OXIDGRUPPEN UND DEREN VERWENDUNG ALS PHOSPHODIESTERASE 4 HEMMER
Title (fr)
5-HYDROXY-INDOLES COMPORTANT DES GROUPES N-OXYDE ET LEUR UTILISATION COMME INHIBITEURS DE LA PHOSPHODIESTERASE 4
Publication
Application
Priority
- EP 2004004340 W 20040423
- DE 10318609 A 20030424
Abstract (en)
[origin: WO2004094406A1] The invention relates to substituted 5-hydroxyindoles with N-oxide groups, a method for the production thereof, pharmaceutical preparations which contain said compounds and the pharmaceutical use of said compounds which are inhibitors of phosphodiesterase 4, as active substances in the treatment of diseases which can be influenced by the said inventive compounds by means of an inhibition of phosphodiesterase 4 activity, especially in immunocompetent cells (for example, macrophages and lymphocytes).
IPC 1-7
IPC 8 full level
C07D 401/12 (2006.01)
CPC (source: EP KR US)
A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/12 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/02 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 11/08 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 13/04 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/04 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/08 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/30 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 27/14 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 31/18 (2017.12 - EP); A61P 33/02 (2017.12 - EP); A61P 33/06 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 401/12 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2004094406A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004094406 A1 20041104; AR 044079 A1 20050824; AU 2004232484 A1 20041104; BR PI0409683 A 20060418; CA 2523062 A1 20041104; CN 1777599 A 20060524; DE 10318609 A1 20041111; EP 1615911 A1 20060118; JP 2006524210 A 20061026; KR 20060014035 A 20060214; MX PA05011435 A 20051212; NO 20055518 D0 20051122; NO 20055518 L 20060118; RU 2005136426 A 20060320; TW 200505448 A 20050216; US 2004266760 A1 20041230; ZA 200506764 B 20060726
DOCDB simple family (application)
EP 2004004340 W 20040423; AR P040101394 A 20040423; AU 2004232484 A 20040423; BR PI0409683 A 20040423; CA 2523062 A 20040423; CN 200480010937 A 20040423; DE 10318609 A 20030424; EP 04729060 A 20040423; JP 2006505247 A 20040423; KR 20057019983 A 20051021; MX PA05011435 A 20040423; NO 20055518 A 20051122; RU 2005136426 A 20040423; TW 93110112 A 20040412; US 82434204 A 20040414; ZA 200506764 A 20050824